Goldman Sachs’s Longevity Health Holdings XAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding XAGE
Goldman Sachs's XAGE Position: Q4 2023 in Review
Goldman Sachs sold out of Longevity Health Holdings (XAGE) in Q4 2023, closing a stake of 571 shares — an estimated $61.7K sold.
Goldman Sachs first reported a position in XAGE in Q3 2021 and held it in 9 quarters. The position peaked at $4.29M in Q2 2023. 14 funds tracked by Wall St. Rank hold XAGE as of Q4 2023.
- Goldman Sachs reported no remaining Longevity Health Holdings position as of Q4 2023 after selling out during the quarter.
- Goldman Sachs sold 571 Longevity Health Holdings shares in Q4 2023, an estimated $61.7K.
- Goldman Sachs first reported a position in Longevity Health Holdings in Q3 2021 and held it in 9 quarters.
- Goldman Sachs's Longevity Health Holdings position peaked at $4.29M in Q2 2023.
- 14 funds tracked by Wall St. Rank held Longevity Health Holdings as of Q4 2023.
Based on Goldman Sachs's 13F filing for Q4 2023, filed 13 Feb 2024.